Home › NDC Lookup › RxCUI directory › RxCUI 1086613

Mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment [Lubrifresh P.M.] — RxCUI 1086613

RxNorm drug concept · Semantic branded drug
RxCUI 1086613 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1086613
Official nameMineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment [Lubrifresh P.M.]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLubrifresh PM (mineral oil 15 % / white petrolatum 83 % ) Ophthalmic Ointment; LubriFresh P.M. 15 % / 83 % Ophthalmic Ointment
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)130 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Mineral Oil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That depends on how you take it. If you use a rectal enema, you can expect a bowel movement in about 2 to 15 minutes. If you take the oral liquid, it generally takes 6 to 8 hours —...
  • How long does it take mineral oil to work?
  • You need to be careful here. Mineral oil can change how other drugs are absorbed into your body. The general rule is to take mineral oil at least 2 hours before or after any other...
  • Can I take mineral oil with my other medications?
📖 Read our full Mineral Oil guide →

🕸️ Concept Web — How Mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG O... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment [Lubrifresh P.M.] RxCUI 1086613

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Mineral oil 6972
    • Petrolatum 8091
    • Mineral oil / petrolatum 691286
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lubrifresh P.M. 1086610
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Mineral oil / petrolatum Ophthalmic Ointment 376515
    • Mineral oil / petrolatum Ophthalmic Product 1164734
    • Mineral oil / petrolatum Ophthalmic Ointment [Lubrifresh P.M.] 1086612
    • Lubrifresh P.M. Ophthalmic Product 1180949
    • Ophthalmic Ointment 91344
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG [Lubrifresh P.M.] SBDC · 1086611
  • Mineral oil / petrolatum Ophthalmic Ointment [Lubrifresh P.M.] SBDF · 1086612
  • Lubrifresh P.M. Ophthalmic Product SBDG · 1180949
  • Lubrifresh P.M. BN · 1086610

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1086613 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-7540-12 1 TUBE in 1 BOX (0904-7540-12) / 3.5 g in 1 TUBE LubriFresh PM Major Pharmaceuticals 2025-07-21
11716-7540-01 1 TUBE in 1 BOX (11716-7540-1) / 3.5 g in 1 TUBE LubriFresh PM Hanlim Pharm Co. , LTD 2025-07-21
Observed labelers: Hanlim Pharm Co. , LTD (1) · Major Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$1.6562
Range $1.6562–$1.6562 · middle 50% $1.6562–$1.6562 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.